2017 Warren Triennial Prize

First awarded in 1871, the Warren Triennial Prize recognizes scientists who are seekers of and contributors to new knowledge in the service of medicine. The Warren Prize is awarded every three years, and 23 previous winners have gone on to win the Nobel Prize.

The winner of the Warren Prize is awarded $50,000 and the Warren Medallion.

The Warren Triennial Prize and Symposium
April 5, 2017
2:00 – 5:00 pm
Simches Research Building, Room 3.110

David N. Louis, MD
ECOR Chair
Chief, Pathology
Massachusetts General Hospital

2:10 – 3:50 pm     CANCER IMMUNOLOGY
David Fisher, MD, PhD

ECOR Vice Chair
Chief, Dermatology
Massachusetts General Hospital

2:10 – 2:35 pm     Drivers, Targets and Resistors of Tumor Immunity
Nir Hacohen, PhD
Associate Professor, Department of Medicine
Harvard Medical School
Director, MGH Center for Cancer Immunology, Center for Cancer Research
Massachusetts General Hospital
Senior Member, Broad Institute

2:35 – 3:00 pm     Multifaceted Functions of the PD-1 Pathway
Arlene Sharpe, MD, PhD
George Fabyan Professor, of Comparative Pathology
Interim Co-Chair, Microbiology and Immunobiology
Co-Director, Evergrande Center for Immunologic Diseases
Harvard Medical School

3:00 – 3:25 pm     Engineered T Cells as Cancer Treatment
Marcela V. Maus, MD, PhD

Assistant Professor, Department of Medicine, Division of Hematology & Oncology
Harvard Medical School
Director, Cellular Immunotherapy, Cancer Center
Massachusetts General Hospital

3:25 – 3:50 pm     Mechanisms of Protective Tumor Immunity
Glenn Dranoff, MD

Global Head, Exploratory Immuno-Oncology
Novartis Institutes for Biomedical Research

3:50 – 4:00 pm     BREAK

Introduction of the Warren Prize and History
Peter L. Slavin, MD
President, Massachusetts General Hospital

2017 Warren Prize Presentation
Daniel A. Haber, MD, PhD

Director, Cancer Center
Massachusetts General Hospital

Immune Blockade in Cancer Therapy: New Insights and Opportunities
James P. Allison, PhD

Professor & Chairman, Immunology
Executive Director, Immunotherapy Platform
The University of Texas MD Anderson Cancer Center

Click here to view a PDF Flyer of the agenda to share with your colleagues.